NEW YORK (GenomeWeb News) – The US Food and Drug Administration and the European Medicines Agency have agreed to accept data for seven kidney toxicity biomarkers as part of the drug approval process, the FDA said today.
 
The agencies will now accept the results of tests that measure the levels of seven proteins found in urine -- KIM-1, albumin, total protein, β2-microglobulin, cystatin C, clusterin, and trefoil factor-3 -- that are indicative of drug-induced damage to kidney cells.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.